NLM Logo

Brentuximab Vedotin MeSH Descriptor Data 2021


MeSH Heading
Brentuximab Vedotin
Tree Number(s)
D12.644.456.217
D12.776.124.486.485.114.224.060.438
D12.776.124.790.651.114.224.060.469
D12.776.377.715.548.114.224.200.469
Unique ID
D000079963
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000079963
Scope Note
Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA.
Entry Term(s)
Adcetris
CAC10-1006
SGN-35
cAC10-vcMMAE
Pharm Action
Antineoplastic Agents, Immunological
Immunotoxins
Registry Number
7XL5ISS668
Related Numbers
914088-09-8
Public MeSH Note
2020; BRENTUXIMAB VEDOTIN was indexed under IMMUNOCONJUGATES 2010-2019
History Note
2020 (2010)
Date Established
2020/01/01
Date of Entry
2019/07/08
Revision Date
2019/01/15
Brentuximab Vedotin Preferred
cAC10-vcMMAE Narrower
Adcetris Narrower
CAC10-1006 Narrower
SGN-35 Narrower
page delivered in 0.155s